Page last updated: 2024-11-02

pentobarbital and Mucositis

pentobarbital has been researched along with Mucositis in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Mucositis: An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gui, MX1
Huang, B1
Peng, J1
Chen, X1
Muthu, R1
Gao, Y1
Wang, RG1
Lin, JM1

Other Studies

1 other study available for pentobarbital and Mucositis

ArticleYear
Babao Dan Alleviates 5-Fluorouracil-Induced Intestinal Damage via Wnt/β-Catenin Pathway.
    Chinese journal of integrative medicine, 2022, Volume: 28, Issue:11

    Topics: Animals; Antineoplastic Agents; beta Catenin; Diarrhea; Fluorouracil; Intestinal Mucosa; Male; Mice;

2022